.png "ACSGCI"){kind=logo}
The ACS GCI Pharmaceutical Roundtable is seeking a one year R&D commitment to assist the Roundtable’s biopharma initiative. The focus of the R&D will be toward optimizing the water use in downstream processing steps for monoclonal antibody (mAb) production. Proposals are invited from public and private institutions of higher education worldwide. This collaborative project is intended for a student within the selected Principal Investigator’s research group. One grant is planned to be awarded and the total award is limited to $50,000 for a grant period of 12 months. Interested PI’s are required to provide a written proposal describing the investigator’s capability to carry out the Roundtable’s proposed research.
Deadline for receipt of proposals is January 31, 2016 at 5 pm EDT. All submissions must be emailed to gcipr@acs.org. The Principal Investigator with the selected proposal will be notified by March 1, 2016. It is expected that research will commence in the principal investigator’s lab by May 2016 and last approximately 12 months.
Requirements for Submission
Proposals will only be accepted from public and private institutions of higher education. The grant is not limited to institutions in the United States. Proposals must be submitted as a single pdf file by email to gcipr@acs.org through the appropriate institutional office for external funding. For international submissions, if there is no comparable office, submit a pdf of a letter signed by an appropriate university official recognizing the terms of the grant.
Download the full grant RFP.
“The Nexus Blog” is a sister publication of “The Nexus” newsletter. To sign up for the newsletter, please email gci@acs.org, or if you have an ACS ID, login to your email preferences and select “The Nexus” to subscribe.
To read other posts, go to Green Chemistry: The Nexus Blog home.